Today, Coronavirus Disease 2019 (COVID-19) is a global public health emergency and vaccination measures to counter its diffusion are deemed necessary. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), the etiological agent of the disease, unleashes a T-helper 2 immune response in those patients requiring intensive care. Here, we illustrate the immunological mechanism to train the immune system towards a more effective and less symptomatic T-helper 1 immune response, to be exploited against SARS-CoV-2.
All Keywords
【저자키워드】 Vaccine, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), Coronavirus disease 2019 (COVID-19), Hyaluronic acid, Bacillus Calmette-Guérin (BCG),Corynebacterium parvum (C. parvum ), Propionibacterium acnes (P. acnes ), Cutibacterium acnes (C. acnes ), cluster of differentiation 44 (CD44), T helper 1 (Th1), T helper 2 (Th2),
【저자키워드】 Vaccine, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), Coronavirus disease 2019 (COVID-19), Hyaluronic acid, Bacillus Calmette-Guérin (BCG),